Accession Number: | 0000899243-21-016010 |
Date: | 2021-04-13 |
Issuer: | TREVI THERAPEUTICS, INC. (TRVI) |
Original Submission Date: |
GALLETTA CHRISTOPHER
C/O TREVI THERAPEUTICS, INC.
195 CHURCH STREET, 14TH FLOOR
NEW HAVEN, CT 06510
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.53 | 2021-04-13 | deemed execution date | A | 25,000 (a) | 2031-04-12 | common stock 25,000 | $2.53 | 25,000 | direct |
ID | footnote |
---|---|
f1 | this option was granted on april 13, 2021. the 25,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on april 12, 2022 and as to the remaining 75% of the shares in equal monthly installments thereafter, through april 12, 2025. |